Publication | Closed Access

Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease

Inflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationMedicineGeneticsGenetic DisorderImmunologySevere Lung DiseasePulmonary FibrosisPulmonary MedicineDisease Gene IdentificationMedical GeneticsLumacaftor/ivacaftor Reduces ExacerbationsPhe508del MutationMolecular Medicine